Clinical trials are the backbone of medical innovation—but delays in patient enrollment can jeopardize timelines, budgets, and even entire studies.
The Enrollment Crisis is Real
Over 80% of clinical trials fail to meet their enrollment targets. What’s slowing them down? Recruitment bottlenecks, rising costs, protocol complexity, and participant drop-offs are just a few of the obstacles. Each delay can cost sponsors millions in lost opportunities.
Outsourcing: The Smarter Path Forward
Today’s CROs and sponsors are embracing specialized outsourcing to solve enrollment challenges head-on. From multilingual contact centers to AI-powered screening tools, outsourcing is no longer just about cutting costs—it’s about boosting speed, compliance, and data quality.
Key Advantages of Clinical Trial Outsourcing:
● Flexibility to scale across trial phases
● Faster recruitment through targeted engagement
● HIPAA and GDPR-compliant communications
● Expert agents trained in trial protocols and patient interaction
● Real-time dashboards and SLA-driven performance
Tech Meets Trial: Tools That Accelerate Success
From eConsent platforms to CRM-powered contact centers, modern tech is reshaping patient enrollment. Predictive algorithms, automated pre-screening, and digital follow-ups help reduce dropouts and speed up recruitment—without increasing your budget.
Your Competitive Advantage Starts Here
Our white paper, Cut Costs, Not Quality: Smarter Strategies for Clinical Trial Enrollment, explores how CROs and sponsors can overcome enrollment delays with precision and confidence. Backed by proven frameworks and real-world insights, this resource is essential reading for decision-makers in clinical development.
You’ve just read a summary of the Cut Costs, Not Quality: Smarter Strategies for Clinical Trial Enrollment white paper.
To access the full white paper in an easy-to-read format (don’t worry, we won’t ask for any of your information), simply click Download White Paper. We hope you find the insights and strategies helpful as you plan your next clinical trial.
If you're ready to discuss how Select VoiceCom can help elevate your strategy in 2025, please BOOK A MEETING with Jeff Velodota, our VP of Business Development.